Find information on Major Depressive Disorder Moderate Recurrent including clinical documentation requirements, ICD-10-CM code F33.1, DSM-5 criteria, diagnostic assessment, treatment options, and medical billing guidelines. This resource provides healthcare professionals with accurate and up-to-date information for proper diagnosis, coding, and management of recurrent moderate depression in clinical settings. Learn about symptom identification, severity specifiers, differential diagnosis, and best practices for patient care.
Also known as
Major depressive disorder
Characterized by persistent sadness and loss of interest.
Recurrent depressive disorder
Repeated episodes of major depression with periods of recovery.
Reaction to severe stress, and adjustment disorders
Difficulties coping with stressful life events, sometimes inducing depression.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis Major Depressive Disorder?
Yes
Is it recurrent?
No
Do not code as Major Depressive Disorder. Review clinical documentation for alternative diagnosis.
When to use each related code
| Description |
|---|
| Major Depression, Moderate Recurrent |
| Major Depression, Single Episode, Moderate |
| Dysthymia (Persistent Depressive Disorder) |
Q: How to differentiate Major Depressive Disorder, Moderate Recurrent from Persistent Depressive Disorder (Dysthymia) in clinical practice?
A: Differentiating Major Depressive Disorder, Moderate Recurrent (MDD-MR) from Persistent Depressive Disorder (Dysthymia) requires careful assessment of symptom duration and intensity. MDD-MR is characterized by distinct episodes of major depression lasting at least two weeks, interspersed with periods of remission. Dysthymia, on the other hand, presents as a more chronic, low-grade depressed mood lasting for at least two years, with symptoms never absent for more than two months. While both conditions share core depressive symptoms like low mood, loss of interest, and sleep disturbances, the key differentiator lies in the cyclical nature of MDD-MR versus the persistent, enduring nature of Dysthymia. A thorough patient history, including the timeline of symptom onset and duration, is crucial. Explore how standardized assessment tools like the PHQ-9 can aid in the diagnostic process and consider implementing structured interviews to gain a comprehensive understanding of symptom patterns. Explore our resources for validated diagnostic tools for mood disorders.
Q: What are the most effective evidence-based treatment strategies for Major Depressive Disorder, Moderate Recurrent in adults, considering both pharmacological and non-pharmacological approaches?
A: Evidence-based treatment for Major Depressive Disorder, Moderate Recurrent (MDD-MR) in adults involves a combination of pharmacological and non-pharmacological interventions tailored to individual patient needs and preferences. First-line pharmacological treatments typically include selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Non-pharmacological approaches such as Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT), and Behavioral Activation (BA) have demonstrated efficacy in managing MDD-MR. Combining pharmacotherapy with psychotherapy often yields the best outcomes. Consider implementing measurement-based care to monitor treatment response and adjust treatment plans as needed. Learn more about the latest clinical guidelines for MDD-MR treatment to stay up-to-date on best practices and explore our continuing education resources on integrated treatment models for depression.
Patient presents with symptoms consistent with a diagnosis of Major Depressive Disorder, Moderate Recurrent (ICD-10 F33.1, DSM-5 296.32). The patient reports experiencing a depressed mood, characterized by persistent sadness and loss of interest (anhedonia), for the past six weeks. This represents the patient's second major depressive episode, with the first occurring approximately two years ago. Symptoms include significant weight loss (not due to dieting or exercise), insomnia with difficulty falling asleep and early morning awakenings, fatigue, feelings of worthlessness, diminished ability to concentrate, and recurrent thoughts of death, though the patient denies any current suicidal ideation or plan. The patient's daily functioning is moderately impaired, impacting work performance and social relationships. Symptoms meet the criteria for a major depressive episode and are not attributable to any other medical condition, substance use, or bereavement. Differential diagnosis includes persistent depressive disorder (dysthymia), adjustment disorder with depressed mood, and bipolar disorder. A thorough review of systems and medical history was conducted. Treatment plan includes initiation of psychotherapy (cognitive behavioral therapy CBT) and pharmacotherapy with a selective serotonin reuptake inhibitor (SSRI). Patient education was provided regarding medication management, potential side effects, and the importance of adherence to the treatment plan. The patient was also provided with information on local mental health resources and crisis hotlines. Follow-up appointment scheduled in two weeks to monitor symptom response and adjust treatment as needed. Prognosis is generally favorable with appropriate treatment and ongoing support.